• Communications

    Posted in category News by Communications on 12/11/2012

    ABPI publishes position paper on biosimilar medicines

To support its members, the ABPI makes seven recommendations in a position paper on biosimilars which cover areas where action is needed by regulators, HTA agencies, NHS commissioners and NHS healthcare professionals who prescribe or dispense biosimilar medicines.


The use of biotechnology to develop medicines is rapidly growing and it is estimated that biological medicines are likely to become the biggest selling medicinal products by 2016.  

Our position paper on biosimiliars can be downloaded here.

For further information, please contact: Esteban Herrero-Martinez (eherrero-martinez@abpi.org.uk) or Paul Catchpole (pcatchpole@abpi.org.uk).​

Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.